CarbolinesSulfonesPhosphodiesterase 5 InhibitorsPurinesPhosphodiesterase InhibitorsPiperazinesErectile DysfunctionCyclic Nucleotide Phosphodiesterases, Type 53',5'-Cyclic-GMP PhosphodiesterasesPenile ErectionTriazinesImpotence, VasculogenicUrological AgentsVasodilator AgentsCyclic GMPHomosexuality, MaleMethamphetamineGeorgiaPoisonsGene DosageTribulusDosage Compensation, GeneticFlushingDosage FormsUnsafe SexImidazolesPenisCell-Derived MicroparticlesPhosphoric Diester HydrolasesDouble-Blind MethodLower Urinary Tract SymptomsHypertension, PulmonaryCyclic GMP-Dependent Protein KinasesRisk-TakingUrologic DiseasesNociceptionSexual BehaviorCross-Over StudiesTreatment OutcomeProstatic HyperplasiaUrinary TractOxadiazolesNiacinCystathionine beta-SynthaseDrug Administration SchedulePhenylpropionatesHydrogen SulfideDose-Response Relationship, DrugPlacebosSurvivalOncogene Protein v-aktSulfonamidesExercise ToleranceNitroglycerinHypotensionTime FactorsQuinoxalinesPatient SatisfactionDrug CombinationsCardiotonic AgentsDrug Therapy, CombinationGuanylate CyclaseCardiomyopathiesCarnitineAntihypertensive AgentsItaly